Breztri (budesonide/glycopyrrolate/formoterol fumarate), meanwhile, has been approved since 2020 in the US as a maintenance treatment used to reduce exacerbations in people living with chronic obstructive pulmonary disease (COPD).Sales of Breztri were $677 million last year, a rise of 73%, although AZ does not yet break out Airsupra revenues individually, as it is still in the rollout phase.
https://pharmaphorum.com/news/smart-sensor-cleared-use-az-asthma-copd-inhalers
Breztri (budesonide/glycopyrrolate/formoterol fumarate),...
Add ADR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.021M | |||
| Open | High | Low | Value | Volume |
| 1.8¢ | 1.8¢ | 1.8¢ | $3.74K | 207.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 816197 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 283334 | 3 |
View Market Depth
| Last trade - 16.10pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
1.9¢ |
Change
0.000 ( 5.56 %) |
||||
| Open | High | Low | Volume | ||
| 1.9¢ | 1.9¢ | 1.9¢ | 30000 | ||
| Last updated 14.24pm 16/05/2024 ? | |||||
| ADR (ASX) Chart |